FDG PET Evaluation for Marginal Zone Lymphoma and Its Prognostic Role
NCT04333524
·
clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
496
Enrollment
OTHER
Sponsor class
Conditions
Marginal Zone Lymphoma
Sponsor
International Extranodal Lymphoma Study Group (IELSG)